Debates in EC Management: How to choose First-line therapy for your metastatic EC patient

New ESGO Live Webinar:

Debates in EC Management:

How to choose First-Line therapy for your metastatic EC patient

Friday, November 29th, 2024 |  14:00 CEST  (Time zone conversions)

 

Chairs: Alexandra Leary, France & AnnaMaria Fererro, Italy

Join us for a stimulating live webinar featuring worldleading experts from Europe, Asia–Pacific, Latin America, and the Middle East as they engage in impactful debates addressing key challenges in metastatic endometrial cancer therapy.
The webinar is an educational initiative designed mainly for ESGO's non-European members, with panellists from these countries at times that are convenient for them.
Led by Alexandra Leary and Annamaria Ferrero, this 120-minute webinar will dive into four
critical topics in metastatic EC therapy, with panellists presenting contrasting opinions, giving you a wellrounded understanding of both sides of these key issues.

Webinar Topics

Debate1
Is platinum doublet and IO monotherapy enough
for all 1st line EC patients?

Pro: Mansoor Raza Mirza, Denmark

Con: Shaheenah Dawood, UAE

Experts weigh in on whether this standard approach is universally applicable.

Debate2
What is the best strategy for pMMR
1st line EC patients?

Pro: Els Van Nieuwenhuysen, Belgium

Con: Shannon Westin, USA

Panellists explore IO + PARPi for all versus biomarker-restricted treatments.

Debate3
TP53m pMMR impact on treatment decisions?

Pro: Alexandra Leary, France

Con: Annamaria Ferrero, Italy

Specialists take sides on whether TP53 mutations should guide therapeutic choices.

Debate4
Do we need to test for PD-L1, HRR, and BRCA in EC?

Pro: Byoung-Gie Kim, Republic of Korea

Con: Angelica Nogueirra, Brazil

Panellists engage in a debate on whether these biomarkers are truly predictive or just prognostic.

Throughout the session, you will have the chance to vote in live polls before and after each debate, letting us track how expert insights shape your opinions in real-time.

Don’t miss out on this exclusive opportunity to join the live discussion and gain first-hand knowledge from a panel of world-experienced experts on the challenges professionals face in the management of metastatic endometrial cancer therapy!

Agenda for November 29th, 2024

Agenda_debates

Meet the Webinar Experts Panel

Webinar Co-Chairs:

Alexandra Leary

Institut Gustave Roussy, Villejuif, France

“Our understanding of metastatic endometrial cancer (EC) is evolving every day. Through open dialogues and debates, we can discover better approaches and improve outcomes for patients everywhere.

Join us for an interactive experience that promises to inspire new approaches in metastatic EC treatment.

See you all online!"

Alexandra Leary

 

Annamaria Ferrero

University of Torino, Mauriziano Hospital, Torino, Italy

"Innovation in cancer treatment arises from asking tough questions and exploring every angle. This webinar challenges current thinking and pushes us toward more effective treatments for metastatic endometrial cancer patients.
Don’t miss this opportunity to join a live discussion with a panel of world experts, offering practical insights that could refine and advance your everyday clinical practice."
AnnaMaria Ferrero

Interested in attending?

Don't miss out, reserve your seat now at no cost!
Seats are limited!

AstraZeneca has provided an independent medical education grant towards this Programme.

Upcoming Events

Advanced Course on Surgical Management in Cervical Cancer_2025 ucoming

Advanced Course on Surgical Management in Cervical Cancer

 Online Sessions + Hands-on Madrid, Spain
Level: Advanced

Learn more

1920x1080

ESGO 2025 Congress

 

 

Learn more

Masterclass_2025_Web_ucoming

ESGO-ENYGO Masterclass

 Tbilisi, Georgia
Level: Basic

Find more information here